case_images: PMC5036786_01
case_images: (A) (2007-09-20) Pathological examination revealed a grade II-III invasive ductal carcinoma. (B) (2011-05-12)a left inguinal lymph node revealed a diffuse large B-cell lymphoma. (C) (2011-07-08) Immunotyping showed R2 accounting for 80.77% of the nucleated cells, the expression of CD10(20.91%),CD22(82.24%),CD20(69.85%), CD19(63.50%) and HLA-DR(91.39%). (D) (2011-07-05) Cytological immunotyping examination of the bone marrow morphology showed bone marrow hyperplasia with abnormal lymphoid tissue accounting for 50%, uniform sizes, minimal cytoplasm, blue-colouredcytoplasmwith vacuoles, visibly twisted and folded nuclei, coarse nuclear chromatin and unclear nucleoli. (E) (2011-7-21) Chromosomaltyping showed 46,-X, -1, +7,8q+, -14, -22, +mar2, +mar3, +mar4[5]/46 and xx[5].F:(2011-9-29) A follow-up examination of the bone marrow cytology showed 73% lymphocytes, including 70.5% immature lymphocytes.
case_images: kcbt-17-02-1139233-g001.jpg
case_images: PMC5036786_01_kcbt-17-02-1139233-g001.jpg
case_images: f0001
case_images: The patient refused to continue chemotherapy and received symptomatic supportive treatment before dying in the clinic in February 2012 (Fig. 1).